This inventor holds 0 USPTO granted patents, plus 1 CIPO patent.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Title: Ichiro Yamamoto: Innovator in Pharmaceutical Chemistry
Introduction
Ichiro Yamamoto is a notable inventor based in Japan, recognized for his contributions to pharmaceutical chemistry. His work primarily focuses on the development of novel compounds with significant therapeutic potential. Despite having no patents to his name, his research has led to the creation of innovative chemical derivatives that hold promise for treating various medical conditions.
Latest Patents
Yamamoto's most recent invention involves the synthesis of 4,5-Dihydro-6H-Imidazo[4,5,1-Ij]quinolin-6-One-6-Oxime-O-Sulfonic Acid Derivatives. This invention relates to novel compounds that exhibit potent hypotensive, anti-oedematous, and diuretic effects. The compounds are designed to target specific substituents at the 2-position, such as 2-(2-penten-3-yl)-, 2-cyclohexyl-, 2-naphthyl-, and 2-thienyl-. These compounds are expected to be extremely useful in the treatment of various diseases and disorders.
Career Highlights
Throughout his career, Ichiro Yamamoto has worked with esteemed professionals in the field, contributing to significant advancements in pharmaceutical research. His collaborations have allowed him to explore various aspects of chemical synthesis and compound development.
Collaborations
Yamamoto has collaborated with Hitoshi Inaba, a fellow researcher, to further enhance the scope of their work in pharmaceutical chemistry. Their partnership has been instrumental in the exploration of innovative compounds and their potential applications.
Conclusion
Ichiro Yamamoto's contributions to the field of pharmaceutical chemistry, particularly through his innovative compounds, highlight the importance of research in developing effective treatments for medical conditions. His work continues to inspire future advancements in the industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile